ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
David Christianto , Ni Made Mertaniasih, Ariani Permatasari, Priyo Budi Purwono, Pepy Dwi Endraswari and Atika
Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Article Number: 10740 | © The Author(s). 2025
J Pure Appl Microbiol. 2025;19(4):3095-3105. https://doi.org/10.22207/JPAM.19.4.51
Received: 04 July 2025 | Accepted: 19 November 2025 | Published online: 08 December 2025
Issue online: December 2025
Abstract

Rifampicin-resistant tuberculosis (RR-TB) remains a major public health concern, and is characterized by diagnostic challenges and suboptimal treatment success. To better understand the factors influencing disease burden and outcomes, the present study investigated the clinical, demographic, radiological, and molecular characteristics of patients in a high-burden tertiary hospital in Indonesia. A cross-sectional study involving adult patients diagnosed with RR-TB at Dr. Soetomo General Hospital (Surabaya, Indonesia) was conducted to analyze clinical symptoms, comorbidities, radiographic findings, treatment regimens, and laboratory data, including sputum smear grades and IS6110–IS1081 cycle threshold (CT) values. Among 55 patients with RR-TB (mean age 45.1 years; 60% male), IS6110–IS1081 CT values exhibited significant inverse associations with the Modified Bandim TB Score (p = 0.002) and chest pain (p = 0.003), indicating higher bacterial burden in more symptomatic patients. CT values were also negatively correlated with sputum smear scores (r = -0.342; p = 0.011). Treatment failure was independently associated with anemia (odds ratio [OR] 13.2, p = 0.023) and a long-course regimen (OR 7.3, p = 0.026). A higher bacterial burden, as reflected by lower IS6110–IS1081 CT values, was associated with greater disease severity and chest pain. Anemia and long-course regimens independently predicted treatment failure, highlighting the need for the early detection of patients at high risk and optimized treatment strategies for RR-TB management.

Keywords

Rifampicin-resistant Tuberculosis, Cycle Threshold Value, Sputum Smear, Molecular Diagnostics

Article Metrics

Article View: 114

Share This Article

© The Author(s) 2025. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.